Nitrosatable Drug Exposure during Pregnancy and Adverse Pregnancy Outcome
- 1 December 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 18 (4), 891-899
- https://doi.org/10.1093/ije/18.4.891
Abstract
Olshan A F (Department of Epidemiology, SC-36, University of Washington, Seattle, Washington 98195, USA) and Faustman E M. Nitrosatable drug exposure during pregnancy and adverse pregnancy outcome. International Journal of Epidemiology 1989, 18: 891–899. Recent investigations have suggested that drugs that are amines can undergo endogenous or exogenous nitrosation reactions to form N-nitroso compounds. These compounds have been extensively characterized in animal models as carcinogens, mutagens and teratogens. In order to examine the possible effects of exposure to nitrosatable drugs during gestation on pregnancy outcome, data were utilized from the Collaborative Perinatal Project of the National Institute of Neurological and Communicative Disorders and Stroke. Pregnancy outcomes for 6061 pregnancies in which the mother ingested a drug known to undergo nitrosation were compared with 6921 randomly sampled pregnancies without such exposure. The major outcome factors of interest were birth defects, fetal, neonatal and infant death and birthweight. Our findings suggest that no significant increases in risk of fetal, neonatal and infant death or low birthweight were associated with nitrosatable drug exposure during pregnancy. However, the risk of a tumour in the offspring of exposed mothers was increased (relative risk, RR = 2.29; 95% Cl 0.99–5.26). Increases in relative risk of major malformations was also observed and this increase was greater when exposure during the first four months of pregnancy was examined separately (RR = 1.33; 1.11–1.58). There were specific individual malformations that were observed to have increased relative risks (for example: eye malformations, hydrocephaly, craniosynostosis and meningomyelocoele/meningocoele) but interpretation was difficult due to multiple comparisons and some of these observations were associated with wide confidence intervals. These types of adverse pregnancy outcomes were consistent with animal study outcomes.Keywords
This publication has 15 references indexed in Scilit:
- Formation of DNA‐damaging nitroso compounds by interaction of drugs with nitrite. A preliminary screening for detecting potentially hazardous drugsJournal of Toxicology and Environmental Health, 1985
- N-Nitrosophenacetin: Its Synthesis, Characterization, Mutagenicity, and Teratogenicity2JNCI Journal of the National Cancer Institute, 1984
- Mutagenicity of amine drugs and their products of nitrosationMutation Research/Genetic Toxicology, 1984
- N-NITROSO COMPOUNDS AND CHILDHOOD BRAIN-TUMORS - A CASE-CONTROL STUDY1982
- Teratogenic effects of combined administration of ethylenethiourea and nitrite in miceTeratology, 1980
- RISK FACTORS FOR BRAIN TUMORS IN CHILDRENAmerican Journal of Epidemiology, 1979
- Teratogenic effect ofN-methyl-N′-nitro-N-nitrosoguanidine in miceTeratology, 1978
- Effects of ethylnitrosourea administration during pregnancy on three subsequent generations of bdvi ratsInternational Journal of Cancer, 1977
- Embryonal Neoplasms in the Opossum: A New Model for Solid Tumors of Infancy and ChildhoodScience, 1976
- Teratogenic and Carcinogenic Effects in the Offspring after Single Injection of Ethylnitrosourea to Pregnant RatsNature, 1966